BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37179751)

  • 1. Comprehensive Analysis of Epstein-Barr Virus LMP2A-Specific CD8
    Jo HA; Hyun SJ; Hyun YS; Lee YH; Kim SM; Baek IC; Sohn HJ; Kim TG
    Immune Netw; 2023 Apr; 23(2):e17. PubMed ID: 37179751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of CD4
    Hyun YS; Jo HA; Lee YH; Kim SM; Baek IC; Sohn HJ; Cho HI; Kim TG
    Front Immunol; 2020; 11():602014. PubMed ID: 33658991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of mycobacterium tuberculosis antigen-specific CD4
    Lee YH; Hyun YS; Jo HA; Baek IC; Kim SM; Sohn HJ; Kim TG
    Front Immunol; 2022; 13():897781. PubMed ID: 35967347
    [No Abstract]   [Full Text] [Related]  

  • 4. Comprehensive Analysis of Cytomegalovirus pp65 Antigen-Specific CD8
    Hyun SJ; Sohn HJ; Lee HJ; Lee SD; Kim S; Sohn DH; Hong CH; Choi H; Cho HI; Kim TG
    Front Immunol; 2017; 8():1591. PubMed ID: 29209324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of CD4
    Hyun YS; Lee YH; Jo HA; Baek IC; Kim SM; Sohn HJ; Kim TG
    Front Immunol; 2021; 12():774491. PubMed ID: 35069546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma.
    Jones K; Wockner L; Brennan RM; Keane C; Chattopadhyay PK; Roederer M; Price DA; Cole DK; Hassan B; Beck K; Gottlieb D; Ritchie DS; Seymour JF; Vari F; Crooks P; Burrows SR; Gandhi MK
    Clin Exp Immunol; 2016 Feb; 183(2):206-20. PubMed ID: 26422112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of CD8+ and CD4+ T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCs.
    Sohn DH; Sohn HJ; Lee HJ; Lee SD; Kim S; Hyun SJ; Cho HI; Cho SG; Lee SK; Kim TG
    PLoS One; 2015; 10(5):e0127899. PubMed ID: 26023769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational prediction and identification of Epstein-Barr virus latent membrane protein 2A antigen-specific CD8+ T-cell epitopes.
    Wang B; Yao K; Liu G; Xie F; Zhou F; Chen Y
    Cell Mol Immunol; 2009 Apr; 6(2):97-103. PubMed ID: 19403058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 2 production by alloantigen-stimulated CD4+ and CD8+ human T cell subsets: frequency of HLA class I or class II-reactive precursor cells and clonal specificity of activated T cells.
    Jooss J; Eiermann TH; Wagner H; Kabelitz D
    Immunobiology; 1989 Oct; 179(4-5):366-81. PubMed ID: 2575597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.
    Rajnavölgyi E; Nagy N; Thuresson B; Dosztányi Z; Simon A; Simon I; Karr RW; Ernberg I; Klein E; Falk KI
    Int Immunol; 2000 Mar; 12(3):281-93. PubMed ID: 10700463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.
    Rancan C; Schirrmann L; Hüls C; Zeidler R; Moosmann A
    PLoS Pathog; 2015 Jun; 11(6):e1004906. PubMed ID: 26067064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy.
    Kalra M; Gerdemann U; Luu JD; Ngo MC; Leen AM; Louis CU; Rooney CM; Gottschalk S
    Cytotherapy; 2019 Feb; 21(2):212-223. PubMed ID: 30396848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes.
    Pender MP; Csurhes PA; Pfluger CM; Burrows SR
    BMC Neurol; 2011 Aug; 11():95. PubMed ID: 21810280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBV LMP2A-specific T cell immune responses elicited by dendritic cells loaded with LMP2A protein.
    Chen Y; Sun H; Liu G; Wang B; Wang F; Sun B; Yao K
    Cell Mol Immunol; 2009 Aug; 6(4):269-76. PubMed ID: 19728928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein-Barr virus infection.
    Zhang B; Zong Y; He J; Zhong B; Lin S
    Chin Med J (Engl); 2003 Jun; 116(6):913-7. PubMed ID: 12877806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The B subunit of Escherichia coli enterotoxin helps control the in vivo growth of solid tumors expressing the Epstein-Barr virus latent membrane protein 2A.
    Ondondo B; Faulkner L; Williams NA; Morgan AJ; Morgan DJ
    Cancer Med; 2015 Mar; 4(3):457-71. PubMed ID: 25641882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses.
    Grifoni A; Moore E; Voic H; Sidney J; Phillips E; Jadi R; Mallal S; De Silva AD; De Silva AM; Peters B; Weiskopf D; Sette A
    Front Immunol; 2019; 10():1568. PubMed ID: 31333679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.